image
Roivant Sciences Ltd. ROIV
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 11.2
-3.78 %
$ 8.15 B
Market Cap
1.95
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-03-31 103.65% 531.00% 460.92%
Annual Report FY 10-K 2023-03-31 10.84% -19.37% 13.05%
Annual Report FY 10-K 2022-03-31 132.34% -4.45% -26.22%
Annual Report FY 10-K 2021-03-31 -64.85% -67.41% -101.14%
Annual Report FY 10-K 2020-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-09-30 -87.94% 24.36% -123.61%
Quarterly Report Q1 8-K 2024-06-30 154.96% 132.66% 56.52%
Quarterly Report Q4 8-K 2024-03-31 5.68% -349.52% -13.59%
Quarterly Report Q3 8-K 2023-12-31 117.80% 1547.72% 1905.34%
Quarterly Report Q2 8-K 2023-09-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2023-06-30 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2023-03-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2022-12-31 0.00% 0.00% 0.00%